Jeffrey C Culhane

Title: The Innovations of Jeffrey C. Culhane

Introduction

Jeffrey C. Culhane is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurological and psychiatric disorders. His work has the potential to impact the treatment of various mental health conditions.

Latest Patents

Culhane holds a patent for VMAT2 inhibitor compounds and compositions thereof. This patent includes a compound selected from compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof. These compounds serve as inhibitors of the vesicular monoamine transporter 2 (VMAT2) and are designed to treat neurological and psychiatric diseases and disorders. The patent also discloses compositions containing these compounds in combination with a pharmaceutically acceptable carrier, along with methods for their use in subjects in need.

Career Highlights

Culhane is currently associated with Neurocrine Biosciences, Inc., where he continues to innovate and develop new therapeutic solutions. His work at Neurocrine has positioned him as a key player in the pharmaceutical industry, focusing on groundbreaking treatments for complex health issues.

Collaborations

Throughout his career, Culhane has collaborated with talented professionals, including Nicole Harriott and Donald Nicholas Hettinger. These collaborations have fostered an environment of innovation and have contributed to the advancement of their shared goals in the field of neuroscience.

Conclusion

Jeffrey C. Culhane's contributions to the field of pharmaceuticals, particularly through his patent on VMAT2 inhibitors, highlight his commitment to improving treatment options for neurological and psychiatric disorders. His work continues to inspire advancements in medical science.